About
Small Molecule
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
13
As Collaborator
0
Total Enrollment
1,314
By Phase
PHASE4: 1PHASE1/PHASE2: 1PHASE2: 6PHASE3: 2PHASE1: 2NA: 1
By Status
COMPLETED: 12RECRUITING: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06712407Lead Sponsor
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
PHASE4Recruiting
60 participants
Started: Dec 17, 2024 · Completed: Nov 30, 2027
NCT06274489Lead Sponsor
A Study to Evaluate Setanaxib in Patients With Alport Syndrome
PHASE1/PHASE2Completed
19 participants
Started: Nov 27, 2023 · Completed: Jun 25, 2025
NCT05323656Lead Sponsor
A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
PHASE2Completed
55 participants
Started: Apr 6, 2022 · Completed: Aug 21, 2025
NCT05014672Lead Sponsor
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
PHASE2Completed
76 participants
Started: Feb 14, 2022 · Completed: Jul 2, 2024
NCT04541043Lead Sponsor
Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)
PHASE3Completed
119 participants
Started: Nov 17, 2020 · Completed: Feb 26, 2024
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...